ReviewAnnals of translational medicine2020

Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?-a narrative review.

Christopher Del Prete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.